SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from IntelGenx Technologies Corp. (IGXT) (CIK 0001098880) — Jan 30, 2020

IntelGenx Technologies Corp. (IGXT) (CIK 0001098880)
Date: Jan. 30, 2020 · CIK: 0001098880 · Accession: 0001062993-20-000393

AI Filing Summary & Sentiment

File numbers found in text: 333-235607

Date
January 30, 2020
Author
/s/ Andre Godin
Form
CORRESP
Company
IntelGenx Technologies Corp. (IGXT) (CIK 0001098880)

Letter

IntelGenx Technologies Corp.: CORRESP - Filed by newsfilecorp.com

January 30, 2020 Via EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Healthcare & Insurance

Attn: Ada D. Sarmento

100 F Street, N.E.

Washington, D.C. 20549

Re: Request for Acceleration - IntelGenx Technologies Corp.

Amendment No. 1 to Registration Statement on Form S-1

(SEC File No. 333-235607)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, IntelGenx Technologies Corp. (the "Company"), respectfully requests that the Commission accelerate the effectiveness of the above-referenced Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235607), and permit said Registration Statement to become effective at 4:00 p.m. (Eastern Time) on January 31, 2020, or as soon thereafter as practicable.

The Company hereby authorizes James Guttman, an attorney with our outside legal counsel, Dorsey & Whitney LLP, to orally modify or withdraw this request for acceleration.

Please contact James Guttman of Dorsey & Whitney LLP at (416) 367-7376 with any questions with respect to this request.

Sincerely,
IntelGenx Technologies Corp.

Show Raw Text
CORRESP
1
filename1.htm

    IntelGenx Technologies Corp.: CORRESP - Filed by newsfilecorp.com

    January 30, 2020
Via EDGAR

                United States Securities and Exchange Commission

                Division of Corporation Finance

                Office of Healthcare & Insurance

                Attn: Ada D. Sarmento

                100 F Street, N.E.

                Washington, D.C.  20549

    Re: Request for Acceleration - IntelGenx Technologies Corp.

    Amendment No. 1 to Registration Statement on Form S-1

    (SEC File No. 333-235607)

    Ladies and Gentlemen:

    Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, IntelGenx Technologies Corp. (the "Company"), respectfully requests that the Commission accelerate the effectiveness of the above-referenced Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235607), and permit said Registration Statement to become effective at
    4:00 p.m. (Eastern Time) on January 31, 2020, or as soon thereafter as practicable.

    The Company hereby authorizes James Guttman, an attorney with our outside legal counsel, Dorsey & Whitney LLP, to orally modify or withdraw this request for acceleration.

    Please contact James Guttman of Dorsey & Whitney LLP at (416) 367-7376 with any questions with respect to this request.

            Sincerely,

            IntelGenx Technologies Corp.

            /s/ Andre Godin

            Andre Godin

            President and Chief Financial Officer

    cc: James Guttman, Dorsey & Whitney LLP

        Richard Raymer, Dorsey & Whitney LLP